CN Patent

CN120051456A — 取代的吡啶酮gpr84拮抗剂及其用途

Assigned to Rimino Bioscience Ltd · Expires 2025-05-27 · 1y expired

What this patent protects

本发明提供了化合物、其组合物以及将其用于抑制GRR84和治疗GPR84介导的病症的方法。

USPTO Abstract

本发明提供了化合物、其组合物以及将其用于抑制GRR84和治疗GPR84介导的病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN120051456A
Jurisdiction
CN
Classification
—
Expires
2025-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Rimino Bioscience Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.